Mutating proteins

  • July 25, 2012
Mutating proteins

A paper co-authored by Gates Scholar Guilhem Chalancon shows how bioinformatics approaches can shed new light on the way our bodies produce proteins, which could help design therapeutic strategies for tissue-specific diseases such as cancer.

Scientists have used bioinformatics approaches to shed new light on the way our bodies produce proteins, which could help design therapeutic strategies for tissue-specific diseases such as cancer.

Next-Generation Sequencing technologies have enabled researchers to discover that most human genes are alternatively spliced, a mechanism that allows our genes to produce multiple versions of a protein while starting from a single DNA sequence.  This means the total number of different proteins expressed in our body exceeds by far the over 25,000 produced by our genome.

Very recent studies shed light on the importance of some of these protein versions that are only expressed in certain tissues of our body. One of the studies, co-authored by Gates Cambridge Scholar Guilhem Chalancon, is published in the prestigious journal Molecular Cell and has been featured on the MRC LMB website and in Nature Reviews in Genetics.

The researchers found that tissue-specific alternative splicing not only results in multiple versions of human proteins, but also impacts on the way they interact with each other. Moreover, researchers found that genes that undergo tissue-specific alternative splicing have often mutated in different cancer types.

The researchers used bioinformatics to mine publicly available data. Guilhem [2011], who is doing a PhD in Biological Science at the MRC Laboratory for Molecular Biology, says: “This approach allowed us to pinpoint biological evidence that would be very challenging to characterise otherwise.”

More importantly, he says, it may lead to clinical implications in the future. “Tracking mutations in these portions of genes that are tissue-specific may help to understand better tissue-specific diseases such as cancer and could guide drug development for such diseases,” he says.

More information

Picture credit: Dream designs and www.freedigitalphotos.net

Latest News

Inclusive conservation

Rohini Chaturvedi finished her PhD at a difficult time for many students – in the midst of the global economic crisis of the early 2010s. But through a combination of hard work, initiative and serendipity she has found an impressive way to extend the work she did at Cambridge to promote conservation efforts in India. […]

Research impact award for Gates Cambridge Scholar

A Gates Cambridge Scholar is one of two winners of the 2023 Sandra Dawson Research Impact Award for his work on the economics of climate change earlier this month. The annual award was established through a generous donation from Professor Dame Sandra Dawson, a former Director of Cambridge’s Judge Business School. Winners are chosen based […]

AI system self-organises to resemble brains of complex organisms

A team of Cambridge scientists, co-led by a Gates Cambridge Scholar, have shown that placing physical constraints on an artificially-intelligent system – in much the same way that the human brain has to develop and operate within physical and biological constraints – allows it to develop features of the brains of complex organisms in order […]

Scholar wins history of science & medicine essay prize

A Gates Cambridge Scholar has won a prestigious essay competition about the history of early science with a treatise on evidence of knowledge exchange between the Ming-Chinese and Iberian conventions in the 16th century. The essay competition was run by the Early Sciences Forum of the History of Science Society and the Early Science and Medicine journal […]